Avient Corp (AVNT) Stock Forecast & Price Target

Avient Corporation has demonstrated a strong financial performance, with organic sales increasing by 5% and healthcare sales consistently achieving double-digit growth for six consecutive quarters, culminating in a 14% year-over-year increase in the first half of 2025. Furthermore, four out of nine end markets accounting for 40% of the company's sales are currently experiencing growth, contributing to an overall increase in total organic sales of approximately 2% for 2025. This positive momentum, particularly in the healthcare sector, and resilience in several end markets underscore a favorable outlook for Avient's financial trajectory.

Avient Corp faced a decline in organic sales of approximately 2% in the first quarter of 2024, indicating potential challenges in revenue generation despite later improvements in subsequent quarters, with growth rates fluctuating. The demand for chemicals has shown signs of weakening since mid-2025, raising concerns about volume performance in the latter half of that year. Furthermore, while the depreciation of the dollar may present some benefits, the overall uncertain demand landscape and inconsistent sales trends suggest a potentially negative outlook for the company's financial stability.